These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30177834)

  • 1. A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells.
    Li Y; Zhang H; Zhao Y; Wang C; Cheng Z; Tang L; Gao Y; Liu F; Li J; Li Y; Li Y; Geng N; Rui X; Teng Y; Liu Y; Cao L; Kumar R; Jin F; Li F
    Oncogene; 2019 Feb; 38(6):808-821. PubMed ID: 30177834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK4 phosphorylating RUNX1 promotes ERα-positive breast cancer-induced osteolytic bone destruction.
    Tang L; Gao Y; Song Y; Li Y; Li Y; Zhang H; Li D; Li J; Liu C; Li F
    Int J Biol Sci; 2020; 16(12):2235-2247. PubMed ID: 32549768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells.
    Zhuang T; Zhu J; Li Z; Lorent J; Zhao C; Dahlman-Wright K; Strömblad S
    Oncotarget; 2015 Dec; 6(41):43853-68. PubMed ID: 26554417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
    Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
    J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
    Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
    FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
    Chen D; Sun Y; Wei Y; Zhang P; Rezaeian AH; Teruya-Feldstein J; Gupta S; Liang H; Lin HK; Hung MC; Ma L
    Nat Med; 2012 Oct; 18(10):1511-7. PubMed ID: 23001183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer.
    Sun G; Wang C; Wang S; Sun H; Zeng K; Zou R; Lin L; Liu W; Sun N; Song H; Liu W; Zhou T; Jin F; Shan Z; Zhao Y
    Nucleic Acids Res; 2020 Nov; 48(19):10768-10784. PubMed ID: 32986841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer.
    Magnani L; Patten DK; Nguyen VT; Hong SP; Steel JH; Patel N; Lombardo Y; Faronato M; Gomes AR; Woodley L; Page K; Guttery D; Primrose L; Fernandez Garcia D; Shaw J; Viola P; Green A; Nolan C; Ellis IO; Rakha EA; Shousha S; Lam EW; Győrffy B; Lupien M; Coombes RC
    Oncotarget; 2015 Sep; 6(26):21878-91. PubMed ID: 26215677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
    Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
    J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.
    Park UH; Kang MR; Kim EJ; Kwon YS; Hur W; Yoon SK; Song BJ; Park JH; Hwang JT; Jeong JC; Um SJ
    Oncogene; 2016 Jul; 35(28):3742-52. PubMed ID: 26640146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
    Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
    J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1.
    Xu Z; Yang Y; Li B; Li Y; Xia K; Yang Y; Li X; Wang M; Li S; Wu H
    Cell Death Dis; 2018 May; 9(5):559. PubMed ID: 29752474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines.
    Bandyopadhyay A; Wang L; Chin SH; Sun LZ
    Neoplasia; 2007 Feb; 9(2):113-8. PubMed ID: 17356707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36).
    Chaudhri RA; Olivares-Navarrete R; Cuenca N; Hadadi A; Boyan BD; Schwartz Z
    J Biol Chem; 2012 Mar; 287(10):7169-81. PubMed ID: 22247547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer.
    Zhao Z; Wang L; Xu W
    Oncogene; 2015 Mar; 34(12):1596-607. PubMed ID: 24747967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.
    Croset M; Pantano F; Kan CWS; Bonnelye E; Descotes F; Alix-Panabières C; Lecellier CH; Bachelier R; Allioli N; Hong SS; Bartkowiak K; Pantel K; Clézardin P
    Cancer Res; 2018 Sep; 78(18):5259-5273. PubMed ID: 30042152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors.
    Vargas G; Bouchet M; Bouazza L; Reboul P; Boyault C; Gervais M; Kan C; Benetollo C; Brevet M; Croset M; Mazel M; Cayrefourcq L; Geraci S; Vacher S; Pantano F; Filipits M; Driouch K; Bieche I; Gnant M; Jacot W; Aubin JE; Duterque-Coquillaud M; Alix-Panabières C; Clézardin P; Bonnelye E
    Oncogene; 2019 Feb; 38(7):950-964. PubMed ID: 30478447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.
    Cvetkovic D; Dragan M; Leith SJ; Mir ZM; Leong HS; Pampillo M; Lewis JD; Babwah AV; Bhattacharya M
    Endocrinology; 2013 Jun; 154(6):1999-2014. PubMed ID: 23525242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.